Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events

Mitchell R. Smith, Karim Fizazi, Arun Balakumaran et al.|Annals of Oncology|2014

Cited by 145